Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002503282 | SCV002813666 | likely benign | Polycystic kidney disease, adult type | 2022-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002541297 | SCV003551213 | likely benign | Inborn genetic diseases | 2021-10-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Department of Pathology and Laboratory Medicine, |
RCV002503282 | SCV005913934 | likely benign | Polycystic kidney disease, adult type | 2022-09-15 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001795766 | SCV002036108 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001795766 | SCV002037954 | likely benign | not provided | no assertion criteria provided | clinical testing |